Form D · Biotechnology

AltheaDx, Inc.

San Diego, CA · CIK 0001470592

Offering snapshot reported Dec 9, 2020 · SEC filing

Reported sold
$3.73M
Offering amount: $6.21M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 2, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.86M$3.73MSep 22, 2020: $2,850,504.00Sep 22, 2020Dec 9, 2020: $3,727,542.00Dec 9, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,850,504 → $3,727,542
  • Reported investors5 → 28

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 9, 2020Amendment$3,727,542$877,038vs Sep 22, 202028SEC filing
Sep 22, 2020Initial$2,850,504No comparison5SEC filing
Oct 22, 2019Initial$1,320,353No comparison5SEC filing
Jan 17, 2019Initial$1,681,246No comparison5SEC filing
Aug 10, 2018Initial$1,971,927No comparison6SEC filing
Mar 12, 2018Initial$830,610No comparison5SEC filing
Feb 14, 2017Initial$3,000,001No comparison1SEC filing
Sep 19, 2016Initial$6,000,000No comparison1SEC filing
Jul 15, 2016Initial$2,221,227No comparison5SEC filing
Dec 28, 2015Initial$20,107,472No comparison28SEC filing
Apr 10, 2014Initial$150,000No comparison2SEC filing
Jun 27, 2013Initial$7,249,849No comparison12SEC filing
Aug 20, 2009Initial$3,574,514No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-375963

Source: Form D, filed Dec 9, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey G. Black Executive
Feng Cao Executive
Francois Ferre Director
Jorge Garces Director, Executive
James Glavin Director
Greg Hamilton Director, Executive
Andrew Jackson Executive
Ann Kessler Director
Deval Lashkari Director
Wei Li Director
Jason Liu Director
J. Matthew Mackowski Director
Magda Marquet Director
Joseph Monforte Executive
David Nikodem Director, Executive
Carin Sandvik Executive
Yuh Geng Tsay Director
John Wu Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3030 Bunker Hill Street, Suite 300
San Diego, CA, 92109